WO2003046553A1 - Diagnostics for chronic obstructive pulmonary disease - Google Patents

Diagnostics for chronic obstructive pulmonary disease Download PDF

Info

Publication number
WO2003046553A1
WO2003046553A1 PCT/JP2002/012421 JP0212421W WO03046553A1 WO 2003046553 A1 WO2003046553 A1 WO 2003046553A1 JP 0212421 W JP0212421 W JP 0212421W WO 03046553 A1 WO03046553 A1 WO 03046553A1
Authority
WO
WIPO (PCT)
Prior art keywords
amino acid
acid sequence
same
diagnostics
pulmonary disease
Prior art date
Application number
PCT/JP2002/012421
Other languages
French (fr)
Japanese (ja)
Inventor
Atsushi Nakanishi
Shigeru Morita
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Priority to AU2002354072A priority Critical patent/AU2002354072A1/en
Publication of WO2003046553A1 publication Critical patent/WO2003046553A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

It is intended to provide diagnostics for bronchial asthma or chronic obstructive pulmonary disease. Namely, diagnostics, etc. for respiratory diseases characterized by containing: (1) an antibody against a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO:1; (2) an antibody against a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO:2; and (3) an antibody against a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO:3.
PCT/JP2002/012421 2001-11-29 2002-11-28 Diagnostics for chronic obstructive pulmonary disease WO2003046553A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002354072A AU2002354072A1 (en) 2001-11-29 2002-11-28 Diagnostics for chronic obstructive pulmonary disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-364715 2001-11-29
JP2001364715 2001-11-29

Publications (1)

Publication Number Publication Date
WO2003046553A1 true WO2003046553A1 (en) 2003-06-05

Family

ID=19174855

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/012421 WO2003046553A1 (en) 2001-11-29 2002-11-28 Diagnostics for chronic obstructive pulmonary disease

Country Status (2)

Country Link
AU (1) AU2002354072A1 (en)
WO (1) WO2003046553A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044620A1 (en) * 1998-03-03 1999-09-10 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
WO2001038530A1 (en) * 1999-11-24 2001-05-31 Takeda Chemical Industries, Ltd. Use of disease-associated gene
WO2002014366A2 (en) * 2000-08-16 2002-02-21 Universiteit Utrecht Genes involved in immune related responses observed with asthma

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044620A1 (en) * 1998-03-03 1999-09-10 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
WO2001038530A1 (en) * 1999-11-24 2001-05-31 Takeda Chemical Industries, Ltd. Use of disease-associated gene
WO2002014366A2 (en) * 2000-08-16 2002-02-21 Universiteit Utrecht Genes involved in immune related responses observed with asthma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AGNEL M. ET AL., FEBS LETTERS, vol. 455, no. 3, 1999, pages 295 - 301, XP002945250 *

Also Published As

Publication number Publication date
AU2002354072A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
IL210454A (en) Antibody against a cytokine zcytor17 ligand
WO2002068455A3 (en) Efficient recovery of correctly refolded proteins
WO2007002261A3 (en) IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF
WO2006005707A3 (en) Method for preventing and treating alzheimer´s disease
EP1276756A1 (en) Albumin fusion proteins
WO2006107824A3 (en) Control of n-(phosphonomethyl) iminodiacetic acid conversion in manufacture of glyphosate
WO2003020932A1 (en) Novel secretory proteins and dna thereof
WO2003030821A3 (en) Albumin fusion proteins
WO2003048207A3 (en) Anti-dota antibody
AU2001252192A1 (en) Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd)
WO2004082629A3 (en) Novel cyclosporins
WO2007058267A8 (en) Novel protein and gene encoding the protein
WO2002058725A3 (en) Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine
WO2003046553A1 (en) Diagnostics for chronic obstructive pulmonary disease
EP1231270A4 (en) Novel protein and dna thereof
WO2003020759A3 (en) A caspase- 8 binding protein, its preparation and use
WO2002060533A3 (en) Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
WO2003014359A3 (en) A fusion protein
EP1386961A3 (en) Modified reductase and its gene and use thereof
WO2002074034A3 (en) Novel medicament compositions based on anticholinergic agents and endothelin antagonists
AU2003202489A1 (en) Screening method
WO2001002429A3 (en) Angiopoietin-6 and uses thereof
WO2002007740A3 (en) Snake toxin and use thereof as a pharmaceutical
EP1584628A3 (en) Viral protein
WO2003021263A1 (en) Use of g protein-coupled receptor protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP